Scott B. Robinson

1.2k total citations
44 papers, 815 citations indexed

About

Scott B. Robinson is a scholar working on Surgery, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Scott B. Robinson has authored 44 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Epidemiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Scott B. Robinson's work include Cardiac, Anesthesia and Surgical Outcomes (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Scott B. Robinson is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Scott B. Robinson collaborates with scholars based in United States, Norway and Mexico. Scott B. Robinson's co-authors include Gary M. Oderda, Tong J. Gan, Marc J. Gunter, E. Wayne Holden, David J. Thurman, Ann Von Worley, Hoang Nguyen, Richard E. Scranton, Sonia Ramamoorthy and Tong J. Gan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Scott B. Robinson

43 papers receiving 785 citations

Peers

Countries citing papers authored by Scott B. Robinson

Since Specialization

Citations

This map shows the geographic impact of Scott B. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott B. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott B. Robinson more than expected).

Fields of papers citing papers by Scott B. Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott B. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott B. Robinson. The network helps show where Scott B. Robinson may publish in the future.

Co-authorship network of co-authors of Scott B. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott B. Robinson. A scholar is included among the top collaborators of Scott B. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott B. Robinson. Scott B. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence, Incidence, and Treatment Characteristics of Primary Open-Angle Glaucoma Among Medicare Fee-for-Service Beneficiaries 2025 ·Clinical ophthalmology ·(unknown), (unknown), (unknown), Scott B. Robinson, (unknown), (unknown), (unknown), (unknown)	1
2	Elevated lipoprotein(a) in patients with premature atherosclerotic cardiovascular disease: Insights from a large US real-world cohort 2025 ·Journal of clinical lipidology ·(unknown), Anthony Lozama, Barnabie Agatep, (unknown), Iman Mohammadi, Donna McMorrow, Scott B. Robinson, Lonny Reisman, Nathan D. Wong	1
3	Litigation Risk and Environmental Disclosure Decisions 2023 ·SSRN Electronic Journal ·Scott B. Robinson, (unknown), (unknown)	3
4	Environmental Disclosures and ESG Fund Ownership 2023 ·SSRN Electronic Journal ·Scott B. Robinson, Jonathan L. Rogers, (unknown), Laura Wellman	7
5	Clinical and Economic Outcomes in Patients With Metastatic Urothelial Carcinoma Receiving First-Line Systemic Treatment (the IMPACT UC I Study) 2023 ·The Oncologist ·Mehmet Asım Bilen, Scott B. Robinson, (unknown), Jing Peng, (unknown), (unknown), (unknown)	6
6	Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population 2022 ·SHILAP Revista de lepidopterología ·Sanjay Sethi, Barry J. Make, Scott B. Robinson, (unknown), Michael Pollack, Chad Moretz, Jill Dreyfus, (unknown), (unknown), (unknown)	19
7	Comparison of Hospital Length of Stay and Supportive Care Utilization Between Patients Treated with CPX-351 and 7+3 for Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes 2022 ·SHILAP Revista de lepidopterología ·(unknown), Zhun Cao, Craig Lipkin, (unknown), Scott B. Robinson	1
8	Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients 2022 ·Cardiology Research ·Alex C. Spyropoulos, Bríain ó Hartaigh, Zhun Cao, Craig Lipkin, Scott B. Robinson, (unknown), (unknown), Cheng Wang	2
9	Risk factors, resource use, and cost of postoperative low cardiac output syndrome 2020 ·Journal of Thoracic and Cardiovascular Surgery ·Andra E. Duncan, Alex Kartashov, Scott B. Robinson, (unknown), Kan Zhang, John M. Luber, Roberta James, (unknown), Paula M. Bokesch	27
10	In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study 2019 ·Lung ·Michael T. Durheim, Jennifer Judy, Shaun Bender, (unknown), Joseph E. Lucas, Scott B. Robinson, (unknown), Bimal R. Shah, Thomas B. Leonard, Craig Conoscenti, Scott M. Palmer	21
11	A Descriptive Study on Healthcare Utilization and Costs in Secondary Acute Myeloid Leukemia Patients Treated with CPX-351 Versus Those Treated with 7+3 2019 ·Blood ·(unknown), Zhun Cao, Craig Lipkin, Scott B. Robinson, (unknown)	1
12	Draft Opioid-Prescribing Guidelines for Uncomplicated Normal Spontaneous Vaginal Birth 2018 ·Obstetrics and Gynecology ·(unknown), Mary Margaret Huizinga, Scott B. Robinson, (unknown), Arden Handler, (unknown), (unknown), Kee Chan	9
13	Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States 2016 ·CHEST Journal ·R.A. Balk, Sameer S. Kadri, Zhun Cao, Scott B. Robinson, Craig Lipkin, Samuel A. Bozzette	40
14	Impact of postsurgical opioid use and ileus on economic outcomes in gastrointestinal surgeries 2015 ·Current Medical Research and Opinion ·Tong J. Gan, Scott B. Robinson, Gary M. Oderda, Richard E. Scranton, (unknown), Sonia Ramamoorthy	80
15	Patient Outcomes on Day 4 of Intravenous Antibiotic Therapy in Non–Intensive Care Unit Hospitalized Adults With Community-Acquired Bacterial Pneumonia 2014 ·Infectious Diseases in Clinical Practice ·Scott B. Robinson, Frank R. Ernst, Craig Lipkin, Xingyue Huang	3
16	Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD 2013 ·International Journal of COPD ·Vamsi Bollu, Frank R. Ernst, (unknown), Krithika Rajagopalan, Scott B. Robinson, Sidney S. Braman	25
17	Effect of Opioid-Related Adverse Events on Outcomes in Selected Surgical Patients 2013 ·Journal of Pain & Palliative Care Pharmacotherapy ·Gary M. Oderda, Tong J. Gan, (unknown), Scott B. Robinson	165
18	A Comparison of Health-Care Costs in Patients With Chronic Obstructive Pulmonary Disease Using Lightweight Portable Oxygen Systems Versus Traditional Compressed-Oxygen Systems 2008 ·Respiratory Care ·Douglas W. Mapel, Scott B. Robinson, Eva Lydick	8
19	The Direct Medical Costs of Undiagnosed Chronic Obstructive Pulmonary Disease 2008 ·Value in Health ·Douglas W. Mapel, Scott B. Robinson, Homa Dastani, Hemal Shah, Amy Phillips, Eva Lydick	28
20	Estimating Prevalence, Incidence, and Disease‐related Mortality for Patients with Epilepsy in Managed Care Organizations 2005 ·Epilepsia ·E. Wayne Holden, Hoang Nguyen, (unknown), Scott B. Robinson, (unknown), Marc J. Gunter, Ann Von Worley, David J. Thurman	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact